Allergan cites DTC spending as factor in strong Q2 results

Allergan cited strong spending behind DTC and detailing as factors in reporting stronger-than-expected Q2 results. The firm saw solid gains in its eyecare products, breast implants, medical devices for obesity and Botox for a 23% gain over Q2 2006.

You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical


Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.